FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964681599> ?p ?o ?g. }

• W1964681599 endingPage "17" @default.
• W1964681599 startingPage "9" @default.
• W1964681599 abstract "Abstract Introduction The impact of induction immunosuppression on long‐term survival in heart transplant recipients is unclear. Over the past three decades, practices have varied as induction agents have changed and experiences grew. We sought to evaluate the effect of contemporary induction immunosuppression agents in heart transplant recipients with the primary endpoint of survival, utilizing national registry data. Methods We queried the United Network for Organ Sharing ( UNOS ) data registry for all heart transplants from 1987 to 2012. We restricted our analysis to adult (≥18 yr) recipients performed from 2001–2011 (to allow for the potential for a minimum of 12 months post‐transplant follow‐up) who received either: no antibody based induction ( NONE ) or the contemporary agents ( INDUCED ) of either: basiliximab/daclizumab ( IL ‐2Rab), alemtuzumab, or ATG / ALG /thymoglobulin. Kaplan‐Meier estimates of the survival function as well as Cox proportional hazards models were utilized. Results Of the 17 857 heart transplants that met the inclusion criteria, there were 4635 (26%) reported deaths during the follow‐up period. There were 8216 (46%) patients who were INDUCED . Of the INDUCED agents, 55% were IL ‐2Rab, 4% alemtuzumab, and 40% ALG / ATG /thymoglobulin. Donor and recipient characteristics were evaluated. Overall, being INDUCED did not significantly affect survival in univariable (p = 0.522) and multivariable (p = 0.130) Cox models as well as a propensity score adjusted model (p = 0.733). Among those induced, ATG / ALG /thymoglobulin appeared to have superior survival as compared with IL ‐2Rab (log‐rank p = 0.007, univariable hazard ratio [ HR ] = 0.886; 95% CI : 0.811–0.968; p = 0.522). However, in a multivariable Cox model that adjusted for recipient age, VAD , BMI , steroid use, CMV match, and ischemic time, the hazard ratio for ALG / ATG /thymoglobulin vs. IL ‐2Rab was no longer statistically significant ( HR = 0.948; 95% CI : 0.850–1.058; p = 0.341). Conclusion In a contemporary analysis of heart transplant recipients, an overall analysis of induction agents does not appear to impact survival, as compared to no induction immunosuppression. While ALG / ATG /thymoglobulin appeared to have a beneficial effect on survival compared to IL ‐2Rab in the univariable model, this difference was no longer statistically significant once we adjusted for clinically relevant covariates." @default.
• W1964681599 created "2016-06-24" @default.
• W1964681599 creator A5001119371 @default.
• W1964681599 creator A5004776812 @default.
• W1964681599 creator A5005628445 @default.
• W1964681599 creator A5008876887 @default.
• W1964681599 creator A5018773556 @default.
• W1964681599 creator A5036195856 @default.
• W1964681599 creator A5078067868 @default.
• W1964681599 creator A5085195592 @default.
• W1964681599 creator A5091625001 @default.
• W1964681599 date "2014-12-12" @default.
• W1964681599 modified "2023-10-04" @default.
• W1964681599 title "Impact of induction immunosuppression on survival in heart transplant recipients: a contemporary analysis of agents" @default.
• W1964681599 cites W1968059227 @default.
• W1964681599 cites W1974414773 @default.
• W1964681599 cites W1975407804 @default.
• W1964681599 cites W1976230377 @default.
• W1964681599 cites W1989284890 @default.
• W1964681599 cites W1991992331 @default.
• W1964681599 cites W2021294029 @default.
• W1964681599 cites W2023599188 @default.
• W1964681599 cites W2039905679 @default.
• W1964681599 cites W2050173858 @default.
• W1964681599 cites W2055543492 @default.
• W1964681599 cites W2057917270 @default.
• W1964681599 cites W2068240849 @default.
• W1964681599 cites W2070103692 @default.
• W1964681599 cites W2081965157 @default.
• W1964681599 cites W2092180284 @default.
• W1964681599 cites W2102220047 @default.
• W1964681599 cites W2121045317 @default.
• W1964681599 cites W2521725279 @default.
• W1964681599 doi "https://doi.org/10.1111/ctr.12469" @default.
• W1964681599 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25284138" @default.
• W1964681599 hasPublicationYear "2014" @default.
• W1964681599 type Work @default.
• W1964681599 sameAs 1964681599 @default.
• W1964681599 citedByCount "28" @default.
• W1964681599 countsByYear W19646815992016 @default.
• W1964681599 countsByYear W19646815992017 @default.
• W1964681599 countsByYear W19646815992018 @default.
• W1964681599 countsByYear W19646815992019 @default.
• W1964681599 countsByYear W19646815992020 @default.
• W1964681599 countsByYear W19646815992021 @default.
• W1964681599 countsByYear W19646815992022 @default.
• W1964681599 countsByYear W19646815992023 @default.
• W1964681599 crossrefType "journal-article" @default.
• W1964681599 hasAuthorship W1964681599A5001119371 @default.
• W1964681599 hasAuthorship W1964681599A5004776812 @default.
• W1964681599 hasAuthorship W1964681599A5005628445 @default.
• W1964681599 hasAuthorship W1964681599A5008876887 @default.
• W1964681599 hasAuthorship W1964681599A5018773556 @default.
• W1964681599 hasAuthorship W1964681599A5036195856 @default.
• W1964681599 hasAuthorship W1964681599A5078067868 @default.
• W1964681599 hasAuthorship W1964681599A5085195592 @default.
• W1964681599 hasAuthorship W1964681599A5091625001 @default.
• W1964681599 hasConcept C10515644 @default.
• W1964681599 hasConcept C126322002 @default.
• W1964681599 hasConcept C141071460 @default.
• W1964681599 hasConcept C207103383 @default.
• W1964681599 hasConcept C2777630719 @default.
• W1964681599 hasConcept C2778849806 @default.
• W1964681599 hasConcept C2779015954 @default.
• W1964681599 hasConcept C2779719350 @default.
• W1964681599 hasConcept C2780252810 @default.
• W1964681599 hasConcept C2781307858 @default.
• W1964681599 hasConcept C2909675724 @default.
• W1964681599 hasConcept C2910855829 @default.
• W1964681599 hasConcept C2911091166 @default.
• W1964681599 hasConcept C44249647 @default.
• W1964681599 hasConcept C50382708 @default.
• W1964681599 hasConcept C71924100 @default.
• W1964681599 hasConceptScore W1964681599C10515644 @default.
• W1964681599 hasConceptScore W1964681599C126322002 @default.
• W1964681599 hasConceptScore W1964681599C141071460 @default.
• W1964681599 hasConceptScore W1964681599C207103383 @default.
• W1964681599 hasConceptScore W1964681599C2777630719 @default.
• W1964681599 hasConceptScore W1964681599C2778849806 @default.
• W1964681599 hasConceptScore W1964681599C2779015954 @default.
• W1964681599 hasConceptScore W1964681599C2779719350 @default.
• W1964681599 hasConceptScore W1964681599C2780252810 @default.
• W1964681599 hasConceptScore W1964681599C2781307858 @default.
• W1964681599 hasConceptScore W1964681599C2909675724 @default.
• W1964681599 hasConceptScore W1964681599C2910855829 @default.
• W1964681599 hasConceptScore W1964681599C2911091166 @default.
• W1964681599 hasConceptScore W1964681599C44249647 @default.
• W1964681599 hasConceptScore W1964681599C50382708 @default.
• W1964681599 hasConceptScore W1964681599C71924100 @default.
• W1964681599 hasIssue "1" @default.
• W1964681599 hasLocation W19646815991 @default.
• W1964681599 hasLocation W19646815992 @default.
• W1964681599 hasOpenAccess W1964681599 @default.
• W1964681599 hasPrimaryLocation W19646815991 @default.
• W1964681599 hasRelatedWork W1964681599 @default.
• W1964681599 hasRelatedWork W1968059227 @default.
• W1964681599 hasRelatedWork W1974414773 @default.
• W1964681599 hasRelatedWork W1979820196 @default.

• next